Ranibizumab

1 Drug classified under this active ingredient

Anti-VEFG, Monoclonal Antibody. Ranibizumab 10 mg/ml.
VIAL: 1 x 0.23 ml.
PFS: 1 x 0.165 ml. Initial: See lit.
Neovascular (wet) age-related macular
degen. Tmt. adults with visual impair. due
to diabet. mac. edema (DME). Tmt. visual
impair. due to macular edema second. to
retinal vein occlus. (RVO).
C/I: Hypersens., active/suspect. oc./
perioc. infects., severe intraoc. inflamm.